The novel coronavirus disease 2019 (COVID-19) can induce acute respiratory distress
syndrome (ARDS), which can progress to refractory pulmonary failure. In such cases …

Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …

Background Extracorporeal membrane oxygenation (ECMO) has been used extensively for
coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) …

The World Health Organization (WHO) has characterized the disease, coronavirus disease
2019 (COVID-19), as a pandemic on March 11, 2020 (www. who. int). As of March 11, the …

Abstract As coronavirus disease 2019 (COVID-19) cases surge worldwide, an urgent need
exists to enhance our understanding of the role of extracorporeal membrane oxygenation …

A growing body of evidence supports the use of extracorporeal membrane oxygenation
(ECMO) for severe acute respiratory distress syndrome (ARDS) refractory to maximal …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged since
December 2019 in Wuhan city, and has quickly spread throughout China and other …

Objectives: Severe acute respiratory distress syndrome is complicated with coronavirus
disease 2019 and extracorporeal membrane oxygenation support may be necessary in …

Rationale: Whether patients with coronavirus disease (COVID-19) may benefit from
extracorporeal membrane oxygenation (ECMO) compared with conventional invasive …

Methods We prospectively included all patients referred to the five ICUs of the Strasbourg
University Hospital, between March 3 and April 1, 2020, for severe ARDS due to COVID-19 …